Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Tuesday, August 27, 2013
Find Out the Safety of Compounded Drugs Before You Use Them--great tips in this blog post about questions to ask and things to look for
Are compounded medications safe? Well, it depends. It depends on which pharmacy you choose. It depends on the collaboration between you, your physician and your pharmacist. It also depends on your health condition and how you react to certain components in the medications. This is why it is even more important to plan the use of compounded drugs with your physician and pharmacist before you begin to use it.
Does the Food and Drug Administration (FDA) approve these drugs? The FDA has not approved these drugs but they do acknowledge the usefulness of these alternatives to the regular commercially manufactured drugs. Their website says, “FDA believes that pharmacists engaging in traditional pharmacy compounding provide a valuable medical service that is important to patient health.”
continue to read here
Does the Food and Drug Administration (FDA) approve these drugs? The FDA has not approved these drugs but they do acknowledge the usefulness of these alternatives to the regular commercially manufactured drugs. Their website says, “FDA believes that pharmacists engaging in traditional pharmacy compounding provide a valuable medical service that is important to patient health.”
continue to read here
Compounding Pharmacies Should Not Be Operating as Pharmaceutical Manufacturers
Robert G. Bell, Ph.D., is president and owner of Drug and Biotechnology Development LLC.
On October 26, 2012, the FDA issued a Form 483 with five observations to the New England Compounding Center, the company at the center of the storm of the fungal meningitis outbreak associated with more than 400 cases reported in almost 20 states with 29 deaths. During the inspection, the FDA observed contaminated products and listed a number of deficiencies regarding conditions in the clean rooms, environmental controls, and quality procedures. You can view the complete FDA Form 483 here.
continue to read here
On October 26, 2012, the FDA issued a Form 483 with five observations to the New England Compounding Center, the company at the center of the storm of the fungal meningitis outbreak associated with more than 400 cases reported in almost 20 states with 29 deaths. During the inspection, the FDA observed contaminated products and listed a number of deficiencies regarding conditions in the clean rooms, environmental controls, and quality procedures. You can view the complete FDA Form 483 here.
continue to read here
Another Job in Compounding Pharmacy Sales
Pharmaceutical/Compounding Pharmacy Sales Rep (Orlando)
We are looking for Pharmacy Sales Reps in the South Florida Area. Experience is desired but not required. Offering Both Full Time and Part Time positions. 100% Commission with average Sales Rep making 200K. Please reply with you resume attached or Fax 866-625-1709
- Location: Orlando
- Compensation: Average 200K per year - 100% commission
- This is a contract job.
- Principals only. Recruiters, please don't contact this job poster.
- Please do not contact job poster about other services, products or commercial interests.
Posting ID: 4026975739
Posted: 2013-08-26, 1:58PM EDT
Updated: 2013-08-26, 1:58PM EDT
Subscribe to:
Posts (Atom)